Background: Melanoma metastatic to the gastrointestinal (GI) tract is asymp
tomatic or presents with pain, bleeding, or obstruction. To determine wheth
er surgery influences outcomes, we reviewed our experience with this patien
t population.
Methods: Medical records of patients with metastatic melanoma to the GI tra
ct were reviewed. Patients were divided into four groups, i.e., complete re
section, partial debulking, unresectable, or unexplored. Analysis was perfo
rmed using the Kaplan-Meier method.
Results: Fifty patients with melanoma metastatic to the GI tract were ident
ified (40 men and 10 women; mean age, 44 years). Presenting symptoms includ
ed pain (62%), bleeding (28%), and obstruction (18%). Diagnosis was confirm
ed using contrast studies (38%), endoscopy (20%), or computed tomography (3
0%). Thirty-six patients (61%) underwent a total of 39 operations. Seventee
n patients underwent complete resection, whereas 14 underwent partial debul
king. Five patients had unresectable lesions, and 14 patients did not under
go exploration because of medical contraindications. The operative mortalit
y rate was 2.5% (1 of 39). The mean survival times for the unexplored and u
nresected groups were similar (4.1 months). Patients who underwent partial
resection exhibited a longer mean survival time (8.9 months) than did patie
nts in the unresected group (P < .001). The complete-resection group demons
trated a mean survival time of 23.5 months, which was significantly longer
than that for patients who underwent less than complete resection (P < .000
1).
Conclusions: Metastatic melanoma to the GI tract can result in significant
morbidity and death. Surgical resection can be performed safely. Patients f
or whom all sites of disease are completely resected experience significant
improvements in survival times, compared with patients who undergo less th
an complete resection. For selected patients, surgical treatment of metasta
tic melanoma involving the GI tract is appropriate therapy.